Data Integrity in Pharmaceutical & Life Science
Definition of the FDA (21 CFR Part 11, Electronic Records):
Data integrity refers to the completeness, consistency, and accuracy of data. Complete, consistent, and accurate data should be attributable, legible, contemporaneously recorded, original or a true copy, and accurate (ALCOA).
Definition of the UK Gov. Medicines and Healthcare Products Regulatory Agency:
The extent to which all data are complete, consistent and accurate throughout the data lifecycle. Data integrity arrangements must ensure that the accuracy, completeness, content and meaning of data is retained throughout the data lifecycle.